5V6V image
Deposition Date 2017-03-17
Release Date 2017-06-28
Last Version Date 2024-10-23
Entry Detail
PDB ID:
5V6V
Title:
Crystal structure of small molecule aziridine 3 covalently bound to K-Ras G12C
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.72 Å
R-Value Free:
0.20
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:GTPase KRas
Gene (Uniprot):KRAS
Mutagens:G12C/C51S/C80L/C118S
Chain IDs:A, B
Chain Length:170
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Expanding the Scope of Electrophiles Capable of Targeting K-Ras Oncogenes.
Biochemistry 56 3178 3183 (2017)
PMID: 28621541 DOI: 10.1021/acs.biochem.7b00271

Abstact

There is growing interest in reversible and irreversible covalent inhibitors that target noncatalytic amino acids in target proteins. With a goal of targeting oncogenic K-Ras variants (e.g., G12D) by expanding the types of amino acids that can be targeted by covalent inhibitors, we survey a set of electrophiles for their ability to label carboxylates. We functionalized an optimized ligand for the K-Ras switch II pocket with a set of electrophiles previously reported to react with carboxylates and characterized the ability of these compounds to react with model nucleophiles and oncogenic K-Ras proteins. Here, we report that aziridines and stabilized diazo groups preferentially react with free carboxylates over thiols. Although we did not identify a warhead that potently labels K-Ras G12D, we were able to study the interactions of many electrophiles with K-Ras, as most of the electrophiles rapidly label K-Ras G12C. We characterized the resulting complexes by crystallography, hydrogen/deuterium exchange, and differential scanning fluorimetry. Our results both demonstrate the ability of a noncatalytic cysteine to react with a diverse set of electrophiles and emphasize the importance of proper spatial arrangements between a covalent inhibitor and its intended nucleophile. We hope that these results can expand the range of electrophiles and nucleophiles of use in covalent protein modulation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures